Chargement en cours...
Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin
Frameworks that associate cancer dynamic disease progression models with parametric survival models for clinical outcome have recently been proposed to support decision making in early clinical development. Here we developed such a disease progression clinical outcome model for castration-resistant...
Enregistré dans:
| Publié dans: | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4544052/ https://ncbi.nlm.nih.gov/pubmed/26312162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.49 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|